Open access chemical and clinical probes to support drug discovery.
Drug discovery resources in academia and industry are not used efficiently, to the detriment of industry and society. Duplication could be reduced, and productivity could be increased, by performing basic biology and clinical proofs of concept within open access industry-academia partnerships. Chemical biologists could play a central role in this effort.
Edwards
Aled M
AM
Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada. aled.edwards@utoronto.ca
Bountra
Chas
C
Kerr
David J
DJ
Willson
Timothy M
TM
D000818:Animals; D035843:Biomedical Research / Q000191:economics / Q000379:methods* / Q000639:trends; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D055808:Drug Discovery / Q000191:economics / Q000458:organization & administration* / Q000592:standards / Q000639:trends; D004341:Drug Evaluation / Q000191:economics / Q000379:methods* / Q000639:trends; D004345:Drug Industry / Q000191:economics / Q000379:methods* / Q000639:trends; D006801:Humans; D015335:Molecular Probes / Q000737:chemistry*
D015335:Molecular Probes